Carfilzomib Impurity 4 (N-Oxide Impurity)

IMPURITIES

Product Details

CAT No.# CS-P-02588
Category Impurities
CAS NA
Molecular Weight 735.93
Molecular Formula C40H57N5O8
Synonyms: 4-({[(1S)-1-{[(1S)-3-methyl-1-{[(1S)-1-{[(2R)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamoyl}-2-phenylethyl]carbamoyl}butyl]carbamoyl}-3-phenylpropyl]carbamoyl}methyl)morpholin-4-ium-4-olate
References: Fostier, K., et al.: Ocotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med.chem., 56, 1262 (2013); cCormck, P.L., et al.: Drugs., 72, 2023 (2012);
Shipping: Free Shipping for worldwide on order above 2000 USD
COA / MSDS:    View COA    MSDS
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
Carfilzomib Impurity 4 (N-Oxide Impurity) Worldwide Suppliers of Carfilzomib Impurity 4 (N-Oxide Impurity) Impurities Clearsynth CS-P-02588

Product rating: 9 Carfilzomib Impurity 4 (N-Oxide Impurity) based on 20 ratings

  1. Impurities
  2. Carfilzomib Impurity 4 (N-Oxide Impurity)
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. tibolone (848)
11. (Z)-Dimethylvinphos
12. Silodosin Metabolite
13. 2-Phenoxymethanesulfonanilide
14. Nimesulide EP Impurity A
15. Acetone HPLC
16. Nandrolone Decanoate EP impurity F
17. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
18. Thyroxamine
19. Ortho toluene sulfonic acid
20. Sucrose (1623637)




This page contains information about Carfilzomib Impurity 4 (N-Oxide Impurity) Cas NA and its Impurities.

Carfilzomib Impurity 4 (N-Oxide Impurity) Carfilzomib Impurity 4 (N-Oxide Impurity) Impurities of Carfilzomib Impurity 4 (N-Oxide Impurity) Impurities Clearsynth NA https://www.clearsynth.com/en/temp/CS-P-02588.jpg

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."